A. N. Maniatis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
A. N. Maniatis has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
M. Maniati
Department of Microbiology, School of Medicine, University of Thessalia, Papakyriazi 22, Larissa, Greece
3 shared publicationsCh. Koutsia-Carouzou
Department of Microbiology, General Hospital “Asclepeion”, Voula, Athens
2 shared publicationsE. Petinaki
Department of Microbiology, School of Medicine, University of Thessalia, Papakyriazi 22, Larissa
2 shared publicationsF. Kontos
2 shared publicationsH. Malamou-Lada
Department of Microbiology, General Hospital of Athens “G. Genimatas”, Athens
2 shared publicationsI. Spiliopoulou
Department of Microbiology, School of Medicine, University of Patras, Greece
2 shared publications
Latest Publications
- 9 March 2005
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 25 (4) , 346-348
Rapid increase in numbers of Staphylococcus epidermidis strains with reduced susceptibility to teicoplanin in Greece
- 9 March 2005
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 25 (4) , 346-348
Rapid increase in numbers of Staphylococcus epidermidis strains with reduced susceptibility to teicoplanin in Greece
- 1 February 2004
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 56 (2) , 291-294
Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study
- 1 February 2004
- Published by Elsevier in Journal of Microbiological Methods
- Vol. 56 (2) , 291-294
Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study
- Open Access
- 4 December 2003
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 53 (1) , 105-108
Clonal dissemination of mupirocin-resistant staphylococci in Greek hospitals
Objectives: To determine the rates of mupirocin resistance in staphylococci during a 4 year period (1999–2002) in Greece. Materials: A total of 1200 Staphylococcus aureus and 2760 coagulase-negative staphylococci (CoNS), consecutively collected from four Greek hospitals located in different geographical areas, were tested for susceptibility to mupirocin using the Etest and a reference agar dilution method. Results: Twenty-four S. aureus (2%) and 532 CoNS (19.2%) were found to be mupirocin-resistant during the study period. High-level mupirocin resistance was detected in 20 S. aureus (1.6%) and in 440 CoNS (15.9%), respectively. No variations in the rates of mupirocin-resistant S. aureus in relation to the year of collection were observed. In contrast, the rate of mupirocin-resistant CoNS increased dramatically from 9% in 1999, to 14% in 2000, 20% in 2001 and reached 33% in 2002. PFGE analysis revealed the presence of one main clone (A) among mupirocin-resistant S. aureus and two main clones (i and a) among Staphylococcus epidermidis isolates. Conclusions: In Greece, the rate of mupirocin-resistant S. aureus has remained low and steady since 1999. The high rate of mupirocin-resistant CoNS (33%) in 2002 was due mainly to clonal dissemination of epidemic hospital clones.
- 4 December 2003
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 53 (1) , 105-108
Open AccessClonal dissemination of mupirocin-resistant staphylococci in Greek hospitals
Objectives: To determine the rates of mupirocin resistance in staphylococci during a 4 year period (1999–2002) in Greece. Materials: A total of 1200 Staphylococcus aureus and 2760 coagulase-negative staphylococci (CoNS), consecutively collected from four Greek hospitals located in different geographical areas, were tested for susceptibility to mupirocin using the Etest and a reference agar dilution method. Results: Twenty-four S. aureus (2%) and 532 CoNS (19.2%) were found to be mupirocin-resistant during the study period. High-level mupirocin resistance was detected in 20 S. aureus (1.6%) and in 440 CoNS (15.9%), respectively. No variations in the rates of mupirocin-resistant S. aureus in relation to the year of collection were observed. In contrast, the rate of mupirocin-resistant CoNS increased dramatically from 9% in 1999, to 14% in 2000, 20% in 2001 and reached 33% in 2002. PFGE analysis revealed the presence of one main clone (A) among mupirocin-resistant S. aureus and two main clones (i and a) among Staphylococcus epidermidis isolates. Conclusions: In Greece, the rate of mupirocin-resistant S. aureus has remained low and steady since 1999. The high rate of mupirocin-resistant CoNS (33%) in 2002 was due mainly to clonal dissemination of epidemic hospital clones.
- 13 July 2001
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 18 (1) , 61-65
Methicillin-resistant Staphylococcus aureus in the hospitals of Central Greece
- 13 July 2001
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 18 (1) , 61-65
Methicillin-resistant Staphylococcus aureus in the hospitals of Central Greece